<DOC>
	<DOC>NCT00376285</DOC>
	<brief_summary>The purpose of this study is to determine whether fenofibrate effects the toleration, safety, or efficacy biomarkers of CP-742,033, a drug being developed for the treatment of obesity.</brief_summary>
	<brief_title>Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of CP-742,033</brief_title>
	<detailed_description />
	<mesh_term>Fenofibrate</mesh_term>
	<criteria>BMI of 3040 kg/m2 Women of childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>